Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907417 | PMC |
| http://dx.doi.org/10.3389/fneur.2022.866166 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ISLAND Campus: a fee-free formal university educational intervention in mid- to later-life to reduce modifiable risk factors for dementia and improve cognition.
Front Aging Neurosci
December 2024
Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia.
Introduction: Previous research has tended to focus on early-life education for dementia risk reduction, yet there are great gains for building cognitive reserve in mid- to later-life through educational interventions. ISLAND (Island Study Linking Ageing and Neurodegenerative Disease) Campus offered free university study to all ISLAND participants, with flexible in-person/online learning models to remove educational, socioeconomic and geographical barriers. Here the core hypothesis of ISLAND Campus was investigated: that engagement in later life education leads to improvements in modifiable risk factors for dementia, cognition and blood-based biomarkers.
View Article and Find Full Text PDFPsychotic relapse prediction via biomarker monitoring: a systematic review.
Front Psychiatry
December 2024
Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece.
Background: Associating temporal variation of biomarkers with the onset of psychotic relapse could help demystify the pathogenesis of psychosis as a pathological brain state, while allowing for timely intervention, thus ameliorating clinical outcome. In this systematic review, we evaluated the predictive accuracy of a broad spectrum of biomarkers for psychotic relapse. We also underline methodological concerns, focusing on the value of prospective studies for relapse onset estimation.
View Article and Find Full Text PDFA blood-based mRNA signature distinguishes people with Long COVID from recovered individuals.
Front Immunol
December 2024
Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Bundoora, VIC, Australia.
Introduction: Long COVID is a debilitating condition that lasts for more than three months post-infection by SARS-CoV-2. On average, one in ten individuals infected with SARS CoV- 2 develops Long COVID worldwide. A knowledge gap exists in our understanding of the mechanisms, genetic risk factors, and biomarkers that could be associated with Long COVID.
View Article and Find Full Text PDFEditorial: Biological Therapies and Eating Disorders.
Eur Eat Disord Rev
December 2024
Department for Medical Psychology, Psychosomatics and Psychotherapy, Medical University of Graz, Graz, Austria.
Article Synopsis
- - Blood-based biomarkers and neuroimaging are enhancing our understanding and diagnosis of eating disorders (EDs).
- - The editorial introduces a collection discussing novel biological treatment approaches, including therapies like theta burst stimulation and various pharmacological and microbiome-based treatments.
- - Future research into brain areas linked to memory, emotions, and immune functions may lead to more effective biological treatments for EDs.
Blood-Based Biomarkers and Health-Related Quality of Life Outcomes in Mild TBI: New Insights and Unexpected Associations.
Neurology
January 2025
From the Department of Neuroscience (S.J.M., S.R.S.), Monash University, Melbourne; Department of Neurology (S.J.M., S.R.S.), Alfred Health, Melbourne, Australia; and Health Sciences (S.R.S.), Vancouver Island University, British Columbia, Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!